ImmuPharma plc (IMM.L)
IMM.L Stock Price Chart
Explore ImmuPharma plc interactive price chart. Choose custom timeframes to analyze IMM.L price movements and trends.
IMM.L Company Profile
Discover essential business fundamentals and corporate details for ImmuPharma plc (IMM.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
28 Oct 2003
Employees
5.00
Website
https://www.immupharma.co.ukCEO
Timothy Paul McCarthy XIV, FCCA, MBA
Description
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease. Its other product candidates include BioAMB, a peptide-based drug for the treatment of Amphotericin-B formulations, a fungal infection caused by the aspergillus family of fungi; and BioCin, a peptide-based antibacterial drug used in high medical need cases and in last line of defense. The company has a collaboration arrangement with Centre National de la Recherche Scientifique for the development of a peptide technology platform for treating diabetes with glucagon-like peptide -1 agonists, as well as development of peptides as glucagon antagonists to treat type I and type II diabetes; and license and development agreement with Avion Pharmaceuticals LLC. ImmuPharma plc was founded in 1999 and is headquartered in London, the United Kingdom.
IMM.L Financial Timeline
Browse a chronological timeline of ImmuPharma plc corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 18 May 2026
Upcoming earnings on 8 Sept 2025
Earnings released on 22 May 2025
Earnings released on 19 May 2025
EPS came in at -£0.00.
Earnings released on 30 Sept 2024
EPS came in at -£0.00.
Earnings released on 9 Sept 2024
EPS came in at -£0.00.
Earnings released on 5 Jun 2024
EPS came in at -£0.00.
Earnings released on 10 May 2024
EPS came in at -£0.00, while revenue for the quarter reached -£34.98K.
Earnings released on 30 Sept 2023
EPS came in at -£0.00, while revenue for the quarter reached -£34.98K.
Earnings released on 31 Aug 2023
EPS came in at -£0.00, while revenue for the quarter reached £69.96K.
Earnings released on 23 May 2023
EPS came in at -£0.00, while revenue for the quarter reached £34.98K.
Earnings released on 11 May 2023
EPS came in at -£0.01.
Earnings released on 30 Sept 2022
EPS came in at -£0.00.
Earnings released on 30 Jun 2022
EPS came in at -£0.01.
Earnings released on 31 Mar 2022
EPS came in at -£0.00.
Earnings released on 31 Dec 2021
EPS came in at -£0.02, while revenue for the quarter reached £94.82K.
Dividend declared on 14 Dec 2021
A dividend of £22.70K per share was announced, adjusted to £22.70K.
Earnings released on 30 Sept 2021
EPS came in at -£0.01, while revenue for the quarter reached £47.41K.
Earnings released on 30 Jun 2021
EPS came in at -£0.01, while revenue for the quarter reached £23.53K.
Earnings released on 31 Mar 2021
EPS came in at -£0.01, while revenue for the quarter reached £11.77K.
Earnings released on 31 Dec 2020
EPS came in at -£0.02, while revenue for the quarter reached £64.46K.
Earnings released on 30 Sept 2020
EPS came in at -£0.01, while revenue for the quarter reached £32.23K.
IMM.L Stock Performance
Access detailed IMM.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.